МАВІРЕТ

Product Overview

About МАВІРЕТ

МАВІРЕТ is a prescription medication containing the active ingredients Glecaprevir and pibrentasvir, used to treat chronic hepatitis C virus (HCV) infection in adults with or without cirrhosis. This medication is designed to help patients achieve a sustained virologic response (SVR), which means the virus is no longer detectable in the blood.

Key Benefits & Uses

• Treatment of chronic hepatitis C virus (HCV) infection in adults with or without cirrhosis.
• Achievement of a sustained virologic response (SVR) in patients with HCV genotype 1, 2, 3, 4, 5, or 6 infection.
• Combination therapy with other medications to enhance treatment efficacy.

Active Ingredient & Action

Glecaprevir and pibrentasvir are direct-acting antiviral agents that work by inhibiting the NS3/4A protease and NS5A protein, respectively, which are essential for the replication of the HCV virus. By blocking these proteins, the medication prevents the virus from multiplying and helps the body's immune system to clear the infection.

Important Notes

МАВІРЕТ should only be used under the guidance of a healthcare professional and as part of a comprehensive treatment plan. Patients should be tested for HCV genotype and should not have a history of severe hypersensitivity reactions to the medication. Regular monitoring of liver function and viral load is recommended during treatment.